CStone Pharmaceuticals
CSPHF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.15B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.15 Billion |
|---|---|
| Enterprise Value | $120.91 Million |
| Earnings per Share | $-0.31 |
| Beta | 0.25 |
| Outstanding Shares | 1,521,205,000 |
Return
| Return on Equity | -50.67% |
|---|---|
| Return on Assets | -31.85% |
| Return on Invested Capital | -39.55% |
Valuation & Multiples
| P/E Ratio | -15.32 |
|---|---|
| PEG | -18.19 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.2 |
| Enterprise Value to EBIT | -0.2 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.04 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
$-0.03
Consensus analyst estimateRevenue Estimate
$20.16 M
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
$-0.02
Consensus analyst estimateRevenue Estimate
$37.00 M
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About CStone Pharmaceuticals
102 employees
CEO: Jianxin Yang
CStone Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development, and commercialization of advanced immuno-oncology and precision medicines. Its mission is to address critical unmet medical needs for cancer p...